Women with early-stage breast cancer had a significantly lower rate of febrile neutropenia when given granulocyte-colony stimulating factors (G-CSF) alongside their chemotherapy rather than the ...
Five hundred and six stage I or stage II female breast cancer patients were treated with E 120 mg/m 2 and C 600 mg/m 2 with or without G-CSF and randomly assigned to receive in a factorial 2 × 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback